Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch.
Florian OlomskiVictoria FettelschossSigridur JonsdottirKatharina BirkmannFranziska ThomsEliane MartiMartin F BachmannThomas M KündigAntonia Fettelschoss-GabrielPublished in: Allergy (2020)
TH2-derived IL-31 is involved in IBH pathology and accordingly the immunotherapeutic vaccination approach targeting IL-31 alleviated clinical scores in affected horses.